Prescription drug · ANDA
Lidocan VII (lidocaine 5%) NDC 59088-900
Lidocaine 50 mg/g · Patch · Topical · PURETEK CORPORATION
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 59088-900-54 | 59088090054 | 30 POUCH in 1 PACKAGE (59088-900-54) / 14 g in 1 POUCH (59088-900-84)Marketed from Aug 8, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lidocan VII
- Generic name (nonproprietary)
- lidocaine 5%
- Active ingredients
- Lidocaine — 50 mg/g
- Dosage form
- Patch
- Route
- Topical
- Labeler
- PURETEK CORPORATION
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 209190
- Marketing start
- Listing expires
- Other FDA classes
- Amides (Chemical structure)Local Anesthesia (Physiologic effect)
- Identifiers
- Product ID 59088-900_28dfca0d-997f-5b94-e063-6294a90a755fSPL ID 28dfca0d-997f-5b94-e063-6294a90a755fSPL set ID 1f33d51c-168c-55f2-e063-6394a90a8905RxCUI 1745091, 2642344UNII 98PI200987
- Pharmacologic class
- Amide Local Anesthetic; Antiarrhythmic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N459088090054followed by a unit qualifier and the quantityPackage 59088-0900-54. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Lidocan™ VII is indicated for relief of pain associated with post-herpetic neuralgia. It should be applied only to intact skin.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 209190
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | Asclemed USA, Inc. | 76420-899 |
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | A-S Medication Solutions | 50090-7857 |
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | St. Mary's Medical Park Pharmacy | 60760-657 |
| Lidox 5 Patchlidocaine 5% patch | Lidocaine 50 mg/g | PatchTopical | Injecta Medcial LLC | 87234-0505 |
| Lidocaine 5% Patchlidocaine 5% | Lidocaine 700 mg/1 | PatchTopical | Medcore LLC | 82461-611 |
| Lidocaine 5% | Lidocaine 700 mg/1 | PatchTopical | NuCare Pharmaceuticals,Inc. | 68071-3620 |
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | REMEDYREPACK INC. | 70518-4487 |
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | YARAL Pharma Inc. | 82347-0505 |
| Lidocan IVlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-910 |
| Lidocanlidocaine 5% | Lidocaine 700 mg/1 | PatchTopical | PURETEK CORPORATION | 59088-905 |
| Tridacaine IIIlidocaine | Lidocaine 50 mg/g | PatchTopical | Trifluent Pharma LLC | 73352-835 |
| Lidocan IIIlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-907 |
| Tridacaine XLlidocaine | Lidocaine 50 mg/g | PatchTopical | Trifluent Pharma LLC | 73352-845 |
| Lidocan Vlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-909 |
| Lidocan VIlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-911 |